Vascular Regeneration
Safely grow new blood vessels to restore circulation
The goal is to safely grow new blood vessels — restoring circulation to tissue that has lost its supply — by harnessing the body’s own vessel-building biology, with no new health problems. Restoration of blood flow, not only management of blockage. This page maps each pathway with the science behind it.
Every tissue depends on its blood supply; when vessels narrow or close, the tissue beyond them starves — the root of heart attacks, strokes, and limb loss. For most of medical history, lost circulation could only be bypassed, not regrown. That is changing: the body builds new blood vessels throughout life (angiogenesis), and the science of stimulating that growth — therapeutic angiogenesis — is opening real paths to restoring circulation. Each pathway below names its science and stage.
We are building the capability to safely regenerate blood vessels: stimulating the body’s own vessel-building, repairing the vessel-lining cells, and — at the frontier — engineering new vascular networks, so people recover circulation rather than only routing around its loss.
Each regeneration pathway — capability, science, and stage
Protecting and supporting native vessel growth Demonstrated — clinical
The science: the body grows new vessels throughout life via angiogenesis; physical activity and healthy circulation stimulate it naturally. Supporting this native vessel-building — the most grounded form of regeneration — is the foundation, linked to cardiac and whole-body fitness.
Stimulating therapeutic angiogenesis Clinical / Frontier
The science: therapeutic angiogenesis aims to reconstruct damaged vascular networks by stimulating local vessel growth and new-vessel formation — delivering the body’s own pro-growth signals (such as VEGF and FGF) to ischemic tissue. An emerging strategy, advancing through research toward people.
Repairing the vessel lining Clinical / Frontier
The science: the endothelium — the vessel’s inner lining — is where vascular disease begins; restoring it is central to regeneration. See vessel-wall repair. Healthy endothelium keeps vessels open and able to regrow.
Mobilizing the body’s vessel-builder cells Frontier
The work: endothelial progenitor cells (EPCs) — vessel-building cells from the blood — can be isolated, expanded, and committed to forming new vessel lining. A 2025 meta-analysis found EPCs enhanced new-vessel growth and recovery in injury models. Advancing, with human results still mostly ahead, and labeled frontier.
Reprogramming cells into vessel lining Frontier
The science: a frontier approach reprograms other cells into endothelial cells to rebuild vasculature — using stem-cell and direct-conversion methods. Striking laboratory progress; not yet a human therapy, and we say so plainly.
Engineering vascular networks Frontier
The work: vascular tissue engineering grows new blood-vessel tissue and networks from cells and scaffolds in the lab — a frontier route to rebuilding vasculature. Preclinical and earliest studies.
Restoring blood flow, not just vessels Clinical / Frontier
The north star: regeneration succeeds only when circulation is actually restored — measured as blood flow and tissue recovery. Genuine functional reperfusion, achieved safely, is the measure of success and the link back to vascular health.
Cited as evidence the capability is real — not as partners or endorsers.
Government & programs
the National Heart, Lung, and Blood Institute (NHLBI, NIH), which funds vascular-regeneration and angiogenesis research (all mechanisms).
Angiogenesis researchers
Groups advancing therapeutic angiogenesis — stimulating local vessel growth with the body’s own pro-growth signals (mechanisms 1–2).
Endothelial-cell & EPC researchers
Researchers isolating and expanding endothelial progenitor cells, and reprogramming cells into endothelial lineage, to rebuild vessel lining (mechanisms 4–5).
Vascular tissue-engineering groups
Labs growing blood-vessel tissue and networks from cells and scaffolds (mechanism 6).
Enabling science
angiogenesis and vasculogenesis biology · endothelial and progenitor-cell research · cell reprogramming · vascular tissue engineering.
The technologies span a true spectrum, each at its named stage: native angiogenesis support (grounded, available today), therapeutic angiogenesis (advancing toward people), and the frontier of progenitor-cell mobilization, cell reprogramming, and engineered vascular networks (advancing in the lab and earliest studies). We are precise about which is which.
The body grows new vessels Demonstrated — clinical
Angiogenesis — new-vessel growth — occurs throughout life and can be stimulated, the grounded basis of vascular regeneration.
Therapeutic angiogenesis is advancing Clinical / Frontier
Stimulating local vessel growth to reconstruct damaged networks is an emerging strategy moving through research toward people.
Vessel-builder cells can be harnessed Frontier
Endothelial progenitor cells enhanced new-vessel growth and recovery in injury-model meta-analysis — promising, with human results still mostly ahead.
Engineered vessels are advancing Frontier
Vascular tissue engineering grows vessel tissue and networks in the lab — promising, not yet routine in people.
The honest challenges: vascular regeneration is real but mostly early. The body’s native angiogenesis is genuine and supportable today, but cell-based and engineered vessel regeneration are still largely at the lab and earliest-study stage — much of the strongest evidence is in injury models, with human results ahead. Regenerating vessels is not yet a routine therapy. We are honest about that. But the direction is a genuine turning point: lost circulation is becoming something we can begin to regrow, not only bypass.
The future, fully built
A future where lost circulation can be safely regrown: native vessel-building supported, therapeutic angiogenesis stimulating new growth, the vessel lining repaired, and — as the frontier matures — vascular networks rebuilt and engineered. Lost blood supply becomes, pathway by honest pathway, something we can begin to restore rather than only route around — with no new health problems.
The proof, for this capability
Cited as evidence the capability is real, not as partners or endorsers.
Native angiogenesisDemonstrated (clinical)
The body grows new blood vessels throughout life via angiogenesis; activity and healthy circulation stimulate it — the grounded basis of regeneration.
Therapeutic angiogenesisClinical / Frontier
An emerging strategy to reconstruct damaged vascular networks by stimulating local vessel growth and new-vessel formation with the body’s own pro-growth signals (VEGF, FGF).
Endothelial progenitor cellsFrontier
EPCs — vessel-building cells from blood — can be isolated, expanded, and committed to endothelial lineage; a 2025 meta-analysis found enhanced new-vessel growth and recovery in injury models.
Cell reprogrammingFrontier
Reprogramming other cells into endothelial cells can rebuild vasculature; striking lab progress, not yet a human therapy.
Vascular tissue engineeringFrontier
Blood-vessel tissue and networks grown from cells and scaffolds; preclinical and earliest studies.
Endothelial dysfunction precedes diseaseDemonstrated (clinical)
Endothelial damage precedes vascular disease such as atherosclerosis — making lining repair central to regeneration.
Honest framing
Real organizations and research findings are cited as evidence the capability is real — not as partners or endorsers. The Healthy capability is the safe regeneration of healthy blood vessels, creating no new health problems. Where a step is frontier, we label it frontier.
Help build this future
Every signature grows the movement to make safe vascular regeneration real — and free at the point of need.